For decades, the psychiatric disorder schizophrenia has been treated with drugs that target receptors involved in release of the ‘feel-good neurotransmitter’ dopamine. Now, a new drug Cobenfy that does things differently has been granted US approval. Katrina Megget reports.
Microplastics pollution is growing, with some studies estimating we each ingest 5g of microplastic particles each week on average[1]. So, what are the consequences? Maria Burke reports
Buildings made using mushroom-based materials promise to help reduce emissions from the energy-guzzling construction sector. They have also attracted the interest of NASA – and could form some of the first dwellings on Mars. Anthony King reports